| Affiliation: | 1. Department of Endocrine Neoplasia and Hormonal Disorders, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas;2. Department of Nuclear Medicine and Endocrine Oncology, Gustave Roussy Institute and Université Paris‐Sud, Villejuif, France;3. Department of Nuclear Medicine and Endocrine Oncology, Maria Sklodowska‐Curie Memorial Cancer Center and Institute of Oncology, Wybrzeze Armii Krajowej 15, 44‐101 Gliwice, Poland;4. Department of Thoracic/Head and Neck Oncology, School of Medicine, University of Washington, Seattle, Washington;5. Section of Endocrinology, University of Siena, Siena, Italy;6. Faculty of Medicine, Cancer Genetics Unit, Kolling Institute, Royal North Shore Hospital, University of Sydney, New South Wales, Australia;7. H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida;8. Ohio State University Comprehensive Cancer Center, Columbus, Ohio;9. Department of Geriatrics, University of Arkansas for Medical sciences, Little Rock, Arkansas;10. Department of Endocrinology and Diabetes, The Alfred Hospital, Melbourne, Victoria, Australia;11. Eisai Inc, Woodcliff Lake, New Jersey;12. Eisai Inc, Andover, Massachusetts;13. Cancer Care Services, The Royal Brisbane and Women's Hospital, Herston, Queensland, Australia;14. Department of Endocrinology, University of Pisa, Pisa, Italy;15. Department of Oncology, Royal Marsden Hospital, London, United Kingdom;16. Foundation for Cancer Research and Treatment, National Tumor Institute, Milan, Italy;17. The Johns Hopkins University School of Medicine, Baltimore, Maryland |
